ABC | Volume 112, Nº3, March 2019

Updated The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019 Arq Bras Cardiol. 2019; 112(3):326-368 101. Drezner JA, Sharma S, Baggish A, Papadakis M,WilsonMG, Prutkin JM, et al. International criteria for electrocardiographic interpretation in athletes: Consensus statement. Br J Sports Med. 2017;51(9):704-31. 102. Semsarian C; CSANZ Genetics Council Writing Group. Update on the diagnosis andmanagement of hypertrophic cardiomyopathy. Heart Lung Circ. 2018;27(3):276-9. 103. Dominguez F, González-López E, Padron-Barthe L, Cavero MA, Garcia- Pavia P. Role of echocardiography in the diagnosis and management of hypertrophic cardiomyopathy. Heart. 2018;104(3):261-73. 104. Biffi A, Maron BJ, Culasso F, Verdile L, Fernando F, Di Giacinto B, et al. Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities. Am J Cardiol. 2011;107(5):697-703. 105. Al-KhatibSM,StevensonWG,AckermanMJ,BryantWJ1,CallansDJ,Curtis AB,etal.2017AHA/ACC/HRSGuideline forManagementofPatientsWith Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary. Circulation. 2018;138(13):e210-e271. Erratum in: Circulation. 2018;138(13):e415-e418. 106. Kobayashi S, Sakai Y, Taguchi I, Utsunomiya H, Shiota T. Causes of an increased pressure gradient through the left ventricular outflow tract: a West Coast experience. J Echocardiogr. 2018;16(1):34-41. 107. Quarta G, Aquaro GD, Pedrotti P, Pontone G, Dellegrottaglie S, Iacovoni A. Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy:the importanceofclinicalcontext.EurHeart JCardiovasc Imaging. 2018;19(6):601-10. 108. Marchesini M, Uguccioni L, Parisi R, Mattioli G, Terzi F, Olivieri R. The role of cardiac magnetic resonance imaging in hypertrophic cardiomyopathy. Rev Cardiovasc Med. 2016;17(1-2):57-64. 109. Magrì D, Santolamazza C. Cardiopulmonary exercise test i n h y p e r t r o p h i c c a r d i omy o p a t h y. An n Am T h o r a c S o c . 2017;14(Supplement_1):S102-S109. 110. Coats CJ, Rantell K, Bartnik A, Patel A, Mist B, McKenna WJ, et al. Cardiopulmonary exercise testing and prognosis in hypertrophic cardiomyopathy. Circ Heart Fail. 2015;8(6):1022-31. 111. Sharma S, Elliott P, Whyte G, Jones S, Mahon N, Whipp B, et al. Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. Am J Cardiol. 2000;86(2):162-8. 112. Rowin EJ, Maron BJ, Olivotto I, Maron MS. Role of exercise testing in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging . 2017;10(11):1374-86. 113. Hindieh W, Adler A, Weissler-Snir A, Fourey D, Harris S, Rakowski H. Exercise in patientswithhypertrophiccardiomyopathy:areviewofcurrent evidence, national guideline recommendations and a proposal for a new direction to fitness. J Sci Med Sport. 2017;20(4):333-8. 114. Norrish G, Cantarutti N, Pissaridou E, Ridout DA, Limongelli G, Elliott PM, et al. Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis. Eur J Prev Cardiol. 2017;24(11):1220-30. 115. Weissler-Snir A, Adler A, Williams L, Gruner C, Rakowski H. Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge. Eur Heart J. 2017;38(22):1728-37. 116. Maron MS, Rowin EJ, Olivotto I, Casey SA, Arretini A, Tomberli B, et al. Contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy. J AmColl Cardiol. 2016;67(12):1399-409. 117. Dejgaard LA, Haland TF, LieOH, RibeM, Bjune T, Leren IS, et al. Vigorous exercise in patients with hypertrophic cardiomyopathy. Int J Cardiol. 2018 Jan 1;250:157-63. 118. Tsatsopoulou A. Arrhythmogenic right ventricular cardiomyopathy and pregnancy. Int J Cardiol. 2018 May 1;258:199-200. 119. Wang W, James CA, Calkins H. Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient. Europace. 2018 Apr 23. [Epub ahead of print]. 120. Calkins H, Corrado D, Marcus F. Risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation. 2017;136(21):2068- 82. 121. Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017;376(1):61-72. 122. Tsatsopoulou A, Bossone E. Common presentation of rare diseases: arrhythmogenic right ventricular cardiomyopathy and its mimics. Int J Cardiol. 2018 Apr 15;257:371-7. 123. Etoom Y, Govindapillai S, Hamilton R, Manlhiot C, Yoo SJ, Farhan M, et al. Importance of CMR within the Task Force Criteria for the diagnosis of ARVC in children and adolescents. J Am Coll Cardiol. 2015;65(10):987-95. 124. Zaidi A, Sheikh N, Jongman JK, Gati S, Panoulas VF, Carr-White G. Clinical differentiation between physiological remodeling and arrhythmogenic right ventricular cardiomyopathy in athletes with marked electrocardiographic repolarization anomalies. J Am Coll Cardiol. 2015;65(25):2702-11. 125. Paul M, Meyborg M, Boknik P, Gergs U, Gerss J, Schmitz W, et al. Autonomic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: biochemical evidence of altered signaling pathways. Pacing Clin Electrophysiol. 2014;37(2):173-8. 126. La Gerche A. Defining the interaction between exercise and arrhythmogenic right ventricular cardiomyopathy. Eur J Heart Fail. 2015;17(2):128-31. 127. Haugaa KH, Bundgaard H, Edvardsen T, Eschen O, Gilljam T, Hansen J, et al. Management of patients with Arrhythmogenic Right Ventricular Cardiomyopathy in the Nordic countries. Scand Cardiovasc J. 2015;49(6):299-307. 128. James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H, et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy- associated desmosomal mutation carriers. J Am Coll Cardiol. 2013;62(14):1290-7. 129. Wang W, Orgeron G, Tichnell C, Murray B, Crosson J, Monfredi O, et al. Impact of exercise restriction on arrhythmic risk among patients with arrhythmogenic right ventricular cardiomyopathy. J Am Heart Assoc. 2018;7(12). pii: e008843. 130. Lie OH, Dejgaard LA, Saberniak J, Rootwelt C, Stokke MK, Edvardsen T, et al. Harmful effects of exercise intensity and exercise duration in patients with arrhythmogenic cardiomyopathy. JACC Clin Electrophysiol. 2018;4(6):744-53. 131. Shah N, Phelan DM. Myocarditis in the athlete. Am Coll Cardiol. 2018 Jan 31. [Epub ahead of print]. 132. Trachtenberg BH, Hare JM. Inflammatory cardiomyopathic syndromes. Circ Res. 2017;121(7):803-18. 133. Chandra N, Bastiaenen R, Papadakis M, Sharma S. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol. 2013;61(10):1027-40. 134. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-48. 135. Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet. 2012;379(9817):738- 47. 136. Ukena C, Mahfoud F, Kindermann I, Kandolf R, Kindermann M, BohmM. Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur J Heart Fail. 2011;13(4):398-405 137. Zorzi A, Pelliccia A, Corrado D. Inherited cardiomyopathies and sports participation. Neth Heart J. 2018;26(3):154-65. 138. Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. Lancet. 2017;390(10092):400-14. 361